Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Part of paid clinical trials in Irvine, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT01353430
- Status
- Recruiting
Conditions
- Frontotemporal Dementia
- Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia
- Myopathy
- Paget Disease of Bone
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The investigators are researching families with inherited inclusion body myopathy (IBM) and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also called IBMPFD. IBMPFD is caused by mutations in the VCP gene. Our main goal is to understand how changes in the VCP gene cause the muscle, bone and cognitive problems associated with the disease. The investigators are collecting biological specimen such as blood and urine samples, family and medical histories, questionnaire data of patients with a personal or family history of VCP associated disease. Participants do not need to have all symptoms listed above in order to qualify. A select group of participants may be invited to travel to University of California, Irvine for a two day program of local procedures such as an MRI and bone scan. Samples are coded to maintain confidentiality. Travel is not necessary except for families invited for additional testing.
Key Dates
- Start date
- Nov 15, 2007
- Status verified
- Jun 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: VCP familiesPatients with a personal or family history of VCP associated disease.
Central Contacts
- Virginia Kimonis, MD949 824 0571
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Irvine | Irvine | California | 92697-1385 | Virginia Kimonis, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Irvine, CA
Related Studies
- Phenotype, Genotype & Biomarkers in ALS and Related DisordersEnrolling By Invitation · University of Miami · Palo Alto, California
- First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in DementiaPHASE1/PHASE2 · Recruiting · David Wilson · San Francisco, California
- Imaging of Brain Amyloid Plaques in the Aging PopulationPHASE4 · Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut